Anna Protopapas

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Anna Protopapas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Protopapas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director Class A Common Stock 5,146 $384,714 $74.76 18 Jun 2025 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 3,333 $127,487 $38.25 03 Jun 2021 Direct
Mersana Therapeutics, Inc. Director Common Stock 0 $0 $28.14 06 Jan 2026 Direct
Mersana Therapeutics, Inc. Director Common Stock 0 $0 $28.14 06 Jan 2026 Indirect
Mersana Therapeutics, Inc. Director Restricted Stock Unit 0 $0 $0.5800 15 Jan 2025 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4,147 18 Jun 2025 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 03 Jun 2021 Direct
Mersana Therapeutics, Inc. Director Stock Option (right to buy) 0 06 Jan 2026 Direct

Insider Reports Filed by Anna Protopapas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRSN Mersana Therapeutics, Inc. 06 Jan 2026 20 $0 4 Director 06 Jan 2026, 16:42
NUVL Nuvalent, Inc. 18 Jun 2025 2 $0 4 Director 20 Jun 2025, 16:36
MRSN Mersana Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:58
MRSN Mersana Therapeutics, Inc. 15 Jan 2025 3 -$5,009 4 Director 17 Jan 2025, 19:26
MRSN Mersana Therapeutics, Inc. 14 Jan 2025 3 -$3,900 4 Director 16 Jan 2025, 17:25
MRSN Mersana Therapeutics, Inc. 13 Jan 2025 3 -$7,612 4 Director 15 Jan 2025, 21:20
NUVL Nuvalent, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:12
MRSN Mersana Therapeutics, Inc. 11 Jun 2024 1 $0 4 Director 12 Jun 2024, 16:54
MRSN Mersana Therapeutics, Inc. 13 Jan 2024 9 -$79,671 4 Director 17 Jan 2024, 17:21
NUVL Nuvalent, Inc. 18 Dec 2023 3 -$331,550 4 Director 20 Dec 2023, 16:58
MRSN Mersana Therapeutics, Inc. 11 Sep 2023 2 $0 4 Director 13 Sep 2023, 16:02
NUVL Nuvalent, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:19
MRSN Mersana Therapeutics, Inc. 13 Jan 2023 11 -$99,566 4 President & CEO, Director 18 Jan 2023, 19:24
NUVL Nuvalent, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:17
NUVL Nuvalent, Inc. 30 Mar 2022 1 $0 4 Director 31 Mar 2022, 07:09
NUVL Nuvalent, Inc. 30 Mar 2022 0 $0 3 Director 31 Mar 2022, 07:07
MRSN Mersana Therapeutics, Inc. 14 Jan 2022 5 $0 4 President & CEO, Director 19 Jan 2022, 17:01
MRSN Mersana Therapeutics, Inc. 15 Jul 2021 4 -$513,186 4 President & CEO, Director 19 Jul 2021, 20:49
/report/000139952921000107-protopapas-anna-2021-06-03 Dicerna Pharmaceuticals Inc 03 Jun 2021 2 $0 4 Director 07 Jun 2021, 21:34